{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:09:33Z","timestamp":1792663773821,"version":"4.5.0"},"reference-count":75,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Mesenchymal stromal (stem) cells (MSCs) continue to be a strong area of focus for academic- and industry-based researchers who share the goal of expanding their therapeutic use for diverse inflammatory and immune-mediated diseases. Recently, there has been an accelerated rate of scientific publication, clinical trial activity, and commercialisation in the field. This has included the reporting of exciting new developments in four areas that will be of key importance to future successful use of MSC-based therapies in large numbers of patients: (a) fundamental biology of the primary cells in bone marrow and other tissues that give rise to MSCs in culture. (b) Mechanisms by which MSCs modulate immune and inflammatory responses in vivo. (c) Insights into MSC kinetics, safety, and efficacy in relevant animal disease models. (d) Isolation, definition, and clinical trial-based testing of human MSCs by biomedical companies and academic medical centers. Despite this progress, it remains unclear whether MSCs will enter mainstream therapeutic practice as a frequently used alternative to pharmacotherapy or surgical\/radiological procedures in the foreseeable future. In this review, we summarize some of the most significant new developments for each of the four areas that contribute to the process of translating MSC research to the clinical arena. In the context of this recent progress, we discuss key challenges and specific knowledge gaps which, if not addressed in a coordinated fashion, may hinder the creation of robust \u201ctranslational pipelines\u201d for consolidating the status of MSC-based therapies.<\/jats:p>","DOI":"10.1002\/stem.1452","type":"journal-article","created":{"date-parts":[[2013,6,14]],"date-time":"2013-06-14T09:29:39Z","timestamp":1371202179000},"page":"2033-2041","source":"Crossref","is-referenced-by-count":133,"title":["Concise review: Adult mesenchymal stromal cell therapy for inflammatory diseases: How well are we joining the dots?"],"prefix":"10.1093","volume":"31","author":[{"given":"Matthew D.","family":"Griffin","sequence":"first","affiliation":[{"name":"Regenerative Medicine Institute (REMEDI) College of Medicine, Nursing and Health Sciences, National University of Ireland, Galway, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Elliman","sequence":"additional","affiliation":[{"name":"Orbsen Therapeutics Ltd., University Road, Galway, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emer","family":"Cahill","sequence":"additional","affiliation":[{"name":"Institute of Immunology National University of Ireland, Maynooth, Co., Kildare, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"English","sequence":"additional","affiliation":[{"name":"Institute of Immunology National University of Ireland, Maynooth, Co., Kildare, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhodri","family":"Ceredig","sequence":"additional","affiliation":[{"name":"Regenerative Medicine Institute (REMEDI) College of Medicine, Nursing and Health Sciences, National University of Ireland, Galway, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Ritter","sequence":"additional","affiliation":[{"name":"Regenerative Medicine Institute (REMEDI) College of Medicine, Nursing and Health Sciences, National University of Ireland, Galway, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,10,28]]},"reference":[{"key":"2022011118404299700_stem1452-bib-0001","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1126\/science.284.5411.143","article-title":"Multilineage potential of adult human mesenchymal stem cells","volume":"284","author":"Pittenger","year":"1999","journal-title":"Science"},{"key":"2022011118404299700_stem1452-bib-0002","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S1471-4914(01)02016-0","article-title":"Mesenchymal stem cells: Building blocks for molecular medicine in the 21st century","volume":"7","author":"Caplan","year":"2001","journal-title":"Trend Mol Med"},{"key":"2022011118404299700_stem1452-bib-0003","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/path.2469","article-title":"Why are MSCs therapeutic? New data: New insight","volume":"217","author":"Caplan","year":"2009","journal-title":"J Pathol"},{"key":"2022011118404299700_stem1452-bib-0004","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nm.3028","article-title":"The meaning, the sense and the significance: Translating the science of mesenchymal stem cells into medicine","volume":"19","author":"Bianco","year":"2013","journal-title":"Nat Med"},{"key":"2022011118404299700_stem1452-bib-0005","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/icb.2012.67","article-title":"Anti-donor immune responses elicited by allogeneic mesenchymal stem cells: What have we learned so far?","volume":"91","author":"Griffin","year":"2013","journal-title":"Immunol Cell Biol"},{"key":"2022011118404299700_stem1452-bib-0006","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nri3209","article-title":"Multipotent mesenchymal stromal cells and the innate immune system","volume":"12","author":"Blanc","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"2022011118404299700_stem1452-bib-0007","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/mt.2011.211","article-title":"Mesenchymal stem\/stromal cells (MSCs): Role as guardians of inflammation","volume":"20","author":"Prockop","year":"2012","journal-title":"Mol Ther"},{"key":"2022011118404299700_stem1452-bib-0008","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1136\/gut.2010.215152","article-title":"Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: Results of a phase I study","volume":"59","author":"Duijvestein","year":"2010","journal-title":"Gut"},{"key":"2022011118404299700_stem1452-bib-0009","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0140-6736(08)60690-X","article-title":"Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: A phase II study","volume":"371","author":"Blanc","year":"2008","journal-title":"Lancet"},{"key":"2022011118404299700_stem1452-bib-0010","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.stem.2010.05.012","article-title":"Pharma's developing interest in stem cells","volume":"6","author":"McKernan","year":"2010","journal-title":"Cell Stem Cell"},{"key":"2022011118404299700_stem1452-bib-0011","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1001\/jama.2012.316","article-title":"Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: A randomized controlled trial","volume":"307","author":"Tan","year":"2012","journal-title":"JAMA"},{"key":"2022011118404299700_stem1452-bib-0012","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1136\/gut.2010.214841","article-title":"Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease","volume":"60","author":"Ciccocioppo","year":"2011","journal-title":"Gut"},{"key":"2022011118404299700_stem1452-bib-0013","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1001\/jama.2012.25321","article-title":"Comparison of allogeneic vs autologous bone marrow\u2013derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: The poseidon randomized trial","volume":"308","author":"Hare","year":"2012","journal-title":"JAMA"},{"key":"2022011118404299700_stem1452-bib-0014","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jcyt.2012.11.005","article-title":"Mesenchymal stromal cells: Misconceptions and evolving concepts","volume":"15","author":"Phinney","year":"2013","journal-title":"Cytotherapy"},{"key":"2022011118404299700_stem1452-bib-0015","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nrd3052","article-title":"Challenges with advanced therapy medicinal products and how to meet them","volume":"9","author":"The Committee for Advanced Therapies (CAT)","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"2022011118404299700_stem1452-bib-0016","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2012.00253","article-title":"Cell therapy medicinal product regulatory framework in Europe and its application for MSC based therapy development","volume":"3","author":"Ancans","year":"2012","journal-title":"Front Immunol"},{"key":"2022011118404299700_stem1452-bib-0017","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1084\/jem.20091046","article-title":"Prospective identification, isolation, and systemic transplantation of multipotent mesenchymal stem cells in murine bone marrow","volume":"206","author":"Morikawa","year":"2009","journal-title":"J Exp Med"},{"key":"2022011118404299700_stem1452-bib-0018","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.immuni.2010.08.017","article-title":"The essential functions of adipo-osteogenic progenitors as the hematopoietic stem and progenitor cell niche","volume":"33","author":"Omatsu","year":"2010","journal-title":"Immunity"},{"key":"2022011118404299700_stem1452-bib-0019","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/nature09262","article-title":"Mesenchymal and haematopoietic stem cells form a unique bone marrow niche","volume":"466","author":"Mendez-Ferrer","year":"2010","journal-title":"Nature"},{"key":"2022011118404299700_stem1452-bib-0020","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nature10783","article-title":"Endothelial and perivascular cells maintain haematopoietic stem cells","volume":"481","author":"Ding","year":"2012","journal-title":"Nature"},{"key":"2022011118404299700_stem1452-bib-0021","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nature11926","article-title":"CXCL12 in early mesenchymal progenitors is required for haematopoietic stem-cell maintenance","volume":"495","author":"Greenbaum","year":"2013","journal-title":"Nature"},{"key":"2022011118404299700_stem1452-bib-0022","doi-asserted-by":"crossref","first-page":"6552","DOI":"10.1182\/blood-2010-12-323113","article-title":"Galectin-1\u2013expressing stromal cells constitute a specific niche for pre-BII cell development in mouse bone marrow","volume":"117","author":"Mourcin","year":"2011","journal-title":"Blood"},{"key":"2022011118404299700_stem1452-bib-0023","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.stem.2012.02.003","article-title":"Endogenous bone marrow MSCs are dynamic, fate-restricted participants in bone maintenance and regeneration","volume":"10","author":"Park","year":"2012","journal-title":"Cell Stem Cell"},{"key":"2022011118404299700_stem1452-bib-0024","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3324\/haematol.13740","article-title":"Isolation of functionally distinct mesenchymal stem cell subsets using antibodies against CD56, CD271, and mesenchymal stem cell antigen-1","volume":"94","author":"Battula","year":"2009","journal-title":"Haematologica"},{"key":"2022011118404299700_stem1452-bib-0025","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3324\/haematol.2011.047753","article-title":"The composition of the mesenchymal stromal cell compartment in human bone marrow changes during development and aging","volume":"97","author":"Maijenburg","year":"2012","journal-title":"Haematologica"},{"key":"2022011118404299700_stem1452-bib-0026","doi-asserted-by":"crossref","first-page":"5067","DOI":"10.1182\/blood-2010-08-304287","article-title":"CD146 expression on primary nonhematopoietic bone marrow stem cells is correlated with in situ localization","volume":"117","author":"Tormin","year":"2011","journal-title":"Blood"},{"key":"2022011118404299700_stem1452-bib-0027","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.stem.2008.07.003","article-title":"A perivascular origin for mesenchymal stem cells in multiple human organs","volume":"3","author":"Crisan","year":"2008","journal-title":"Cell Stem Cell"},{"key":"2022011118404299700_stem1452-bib-0028","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.devcel.2011.07.001","article-title":"Pericytes: Developmental, physiological, and pathological perspectives, problems, and promises","volume":"21","author":"Armulik","year":"2011","journal-title":"Developmental Cell"},{"key":"2022011118404299700_stem1452-bib-0029","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1182\/blood-2010-12-327353","article-title":"Anti-inflammatory protein TSG-6 secreted by activated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2\/NF-\u03baB signaling in resident macrophages","volume":"118","author":"Choi","year":"2011","journal-title":"Blood"},{"key":"2022011118404299700_stem1452-bib-0030","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1365-2249.2009.03874.x","article-title":"Cell contact, prostaglandin E2 and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25High forkhead box P3+ regulatory T cells","volume":"156","author":"English","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"2022011118404299700_stem1452-bib-0031","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1097\/TP.0b013e3181fed001","article-title":"Regulatory T-cell generation and kidney allograft tolerance induced by mesenchymal stem cells associated with indoleamine 2,3-dioxygenase expression","volume":"90","author":"Ge","year":"2010","journal-title":"Transplantation"},{"key":"2022011118404299700_stem1452-bib-0032","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1398-9995.2010.02509.x","article-title":"Allogeneic mesenchymal stem cells prevent allergic airway inflammation by inducing murine regulatory T cells","volume":"66","author":"Kavanagh","year":"2011","journal-title":"Allergy"},{"key":"2022011118404299700_stem1452-bib-0033","doi-asserted-by":"crossref","first-page":"5652","DOI":"10.1073\/pnas.0910720107","article-title":"Bone marrow stromal cells use TGF-\u03b2 to suppress allergic responses in a mouse model of ragweed-induced asthma","volume":"107","author":"Nemeth","year":"2010","journal-title":"PNAS"},{"key":"2022011118404299700_stem1452-bib-0034","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/nm.1905","article-title":"Bone marrow stromal cells attenuate sepsis via prostaglandin E2-dependent reprogramming of host macrophages to increase their interleukin-10 production","volume":"15","author":"Nemeth","year":"2009","journal-title":"Nat Med"},{"key":"2022011118404299700_stem1452-bib-0035","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.stem.2012.03.007","article-title":"Mesenchymal-stem-cell-induced immunoregulation involves fas-ligand-\/fas-mediated T cell apoptosis","volume":"10","author":"Akiyama","year":"2012","journal-title":"Cell Stem Cell"},{"key":"2022011118404299700_stem1452-bib-0036","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.4049\/jimmunol.180.3.1598","article-title":"Human Mesenchymal stem cells license adult CD34+ hemopoietic progenitor cells to differentiate into regulatory dendritic cells through activation of the notch pathway","volume":"180","author":"Li","year":"2008","journal-title":"J Immunol"},{"key":"2022011118404299700_stem1452-bib-0037","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1182\/blood-2008-04-154138","article-title":"Mesenchymal stem cells induce mature dendritic cells into a novel Jagged-2\u2013dependent regulatory dendritic cell population","volume":"113","author":"Zhang","year":"2009","journal-title":"Blood"},{"key":"2022011118404299700_stem1452-bib-0038","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1084\/jem.20110132","article-title":"The bone marrow stem cell niche grows up: Mesenchymal stem cells and macrophages move in","volume":"208","author":"Ehninger","year":"2011","journal-title":"J Exp Med"},{"key":"2022011118404299700_stem1452-bib-0039","doi-asserted-by":"crossref","first-page":"302","DOI":"10.4049\/jimmunol.0902007","article-title":"Mesenchymal stem cells inhibit human Th17 cell differentiation and function and induce a T regulatory cell phenotype","volume":"185","author":"Ghannam","year":"2010","journal-title":"J Immunol"},{"key":"2022011118404299700_stem1452-bib-0040","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1002\/eji.201141499","article-title":"Mesenchymal stem cell inhibition of T-helper 17 cell differentiation is triggered by cell\u2013cell contact and mediated by prostaglandin E2 via the EP4 receptor","volume":"41","author":"Duffy","year":"2011","journal-title":"Eur J Immunol"},{"key":"2022011118404299700_stem1452-bib-0041","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1002\/eji.200939584","article-title":"Cell contact interaction between adipose-derived stromal cells and allo-activated T lymphocytes","volume":"39","author":"Quaedackers","year":"2009","journal-title":"Eur J Immunol"},{"key":"2022011118404299700_stem1452-bib-0042","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1038\/cdd.2012.26","article-title":"Mesenchymal stem cells: A double-edged sword in regulating immune responses","volume":"19","author":"Li","year":"2012","journal-title":"Cell Death Differ"},{"key":"2022011118404299700_stem1452-bib-0043","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.imlet.2007.10.002","article-title":"Murine mesenchymal stem cells suppress dendritic cell migration, maturation and antigen presentation","volume":"115","author":"English","year":"2008","journal-title":"Immunol Letters"},{"key":"2022011118404299700_stem1452-bib-0044","doi-asserted-by":"crossref","first-page":"17384","DOI":"10.1073\/pnas.1103650108","article-title":"Mesenchymal stem cells impair in vivo T-cell priming by dendritic cells","volume":"108","author":"Chiesa","year":"2011","journal-title":"PNAS"},{"key":"2022011118404299700_stem1452-bib-0045","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.4049\/jimmunol.177.4.2080","article-title":"Mesenchymal stem cells inhibit generation and function of both CD34+-derived and monocyte-derived dendritic cells","volume":"177","author":"Nauta","year":"2006","journal-title":"J Immunol"},{"key":"2022011118404299700_stem1452-bib-0046","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/icb.2012.62","article-title":"Cellular and molecular interactions of mesenchymal stem cells in innate immunity","volume":"91","author":"Maria Spaggiari","year":"2013","journal-title":"Immunol Cell Biol"},{"key":"2022011118404299700_stem1452-bib-0047","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2012.00212","article-title":"Immunomodulatory effect of mesenchymal stem cells on B cells","volume":"3","author":"Franquesa","year":"2012","journal-title":"Front Immunol"},{"key":"2022011118404299700_stem1452-bib-0048","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.stem.2012.11.016","article-title":"MSCs, Macrophages, and cancer: A dangerous m\u00e9nage-\u00e0-trois","volume":"11","author":"Mantovani","year":"2012","journal-title":"Cell Stem Cell"},{"key":"2022011118404299700_stem1452-bib-0049","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1634\/stemcells.2007-1006","article-title":"Concise Review: Adult multipotent stromal cells and cancer: Risk or benefit?","volume":"26","author":"Lazennec","year":"2008","journal-title":"Stem Cells"},{"key":"2022011118404299700_stem1452-bib-0050","doi-asserted-by":"crossref","first-page":"370","DOI":"10.2174\/157488812802481454","article-title":"Update on cancer related issues of mesenchymal stem cell-based therapies","volume":"7","author":"Wang","year":"2012","journal-title":"Curr Stem Cell Res Ther"},{"key":"2022011118404299700_stem1452-bib-0051","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.stem.2012.10.001","article-title":"Preactivation of human MSCs with TNF-\u03b1 enhances tumor-suppressive activity","volume":"11","author":"Lee Ryang","year":"2012","journal-title":"Cell Stem Cell"},{"key":"2022011118404299700_stem1452-bib-0052","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.stem.2012.08.013","article-title":"CCR2-dependent recruitment of macrophages by tumor-educated mesenchymal stromal cells promotes tumor development and is mimicked by TNF\u03b1","volume":"11","author":"Ren","year":"2012","journal-title":"Cell Stem Cell"},{"key":"2022011118404299700_stem1452-bib-0053","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1111\/j.1582-4934.2011.01509.x","article-title":"Immunogenicity of allogeneic mesenchymal stem cells","volume":"16","author":"Schu","year":"2012","journal-title":"J Cell Mol Med"},{"key":"2022011118404299700_stem1452-bib-0054","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1161\/CIRCULATIONAHA.110.955971","article-title":"Differentiation of allogeneic mesenchymal stem cells induces immunogenicity and limits their long-term benefits for myocardial repair","volume":"122","author":"Huang","year":"2010","journal-title":"Circulation"},{"key":"2022011118404299700_stem1452-bib-0055","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2012.00297","article-title":"Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusion","volume":"3","author":"Eggenhofer","year":"2012","journal-title":"Front Immunol"},{"key":"2022011118404299700_stem1452-bib-0056","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/stem.1271","article-title":"Cell surface structures influence lung clearance rate of systemically infused mesenchymal stromal cells","volume":"31","author":"Nystedt","year":"2013","journal-title":"Stem Cells"},{"key":"2022011118404299700_stem1452-bib-0057","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2013.00041","article-title":"Are cultured mesenchymal stromal cells an option for immunomodulation in transplantation?","volume":"4","author":"Plock","year":"2013","journal-title":"Front Immunol"},{"key":"2022011118404299700_stem1452-bib-0058","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.mvr.2012.02.011","article-title":"Paracrine effects of mesenchymal stem cells enhance vascular regeneration in ischemic murine skin","volume":"83","author":"Schlosser","year":"2012","journal-title":"Microvasc Res"},{"key":"2022011118404299700_stem1452-bib-0059","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1136\/thoraxjnl-2011-201059","article-title":"Mesenchymal stem cells enhance recovery and repair following ventilator-induced lung injury in the rat","volume":"67","author":"Curley","year":"2012","journal-title":"Thorax"},{"key":"2022011118404299700_stem1452-bib-0060","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1089\/scd.2010.0566","article-title":"Preconditioning enhances the paracrine effect of mesenchymal stem cells in preventing oxygen-induced neonatal lung injury in rats","volume":"21","author":"Waszak","year":"2012","journal-title":"Stem Cells Dev"},{"key":"2022011118404299700_stem1452-bib-0061","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1634\/stemcells.2007-0737","article-title":"The anti-inflammatory and anti-angiogenic role of mesenchymal stem cells in corneal wound healing following chemical injury","volume":"26","author":"Oh","year":"2008","journal-title":"Stem Cells"},{"key":"2022011118404299700_stem1452-bib-0062","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1002\/stem.708","article-title":"Action at a distance: Systemically administered adult stem\/progenitor cells (MSCs) reduce inflammatory damage to the cornea without engraftment and primarily by secretion of TNF-\u03b1 stimulated gene\/protein 6","volume":"29","author":"Roddy","year":"2011","journal-title":"Stem Cells"},{"key":"2022011118404299700_stem1452-bib-0063","first-page":"557","article-title":"Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): Implications for therapeutic use","volume":"16","author":"Lazarus","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"2022011118404299700_stem1452-bib-0064","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/TP.0b013e3181ea4240","article-title":"Advancement of mesenchymal stem cell therapy in solid organ transplantation (MISOT)","volume":"90","author":"Hoogduijn","year":"2010","journal-title":"Transplantation"},{"key":"2022011118404299700_stem1452-bib-0065","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1111\/j.1582-4934.2010.01241.x","article-title":"Therapeutic effects of human STRO-3-selected mesenchymal precursor cells and their soluble factors in experimental myocardial ischemia","volume":"15","author":"See","year":"2011","journal-title":"J Cell Mol Med"},{"key":"2022011118404299700_stem1452-bib-0066","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3109\/14653249.2011.651533","article-title":"Single-platform quality control assay to quantify multipotential stromal cells in bone marrow aspirates prior to bulk manufacture or direct therapeutic use","volume":"14","author":"Cuthbert","year":"2012","journal-title":"Cytotherapy"},{"key":"2022011118404299700_stem1452-bib-0067","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/scrt131","article-title":"Characterization of bone marrow derived mesenchymal stem cells in suspension","volume":"3","author":"Akiyama","year":"2012","journal-title":"Stem Cell Res Ther"},{"key":"2022011118404299700_stem1452-bib-0068","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1002\/stem.1111","article-title":"Are therapeutic human mesenchymal stromal cells compatible with human blood?","volume":"30","author":"Moll","year":"2012","journal-title":"Stem Cells"},{"key":"2022011118404299700_stem1452-bib-0069","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.bbmt.2011.07.023","article-title":"Long-term complications, immunologic effects, and role of passage for outcome in mesenchymal stromal cell therapy","volume":"18","author":"Bahr","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"2022011118404299700_stem1452-bib-0070","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jcyt.2012.10.002","article-title":"The mesenchymal stromal cells dilemma\u2014does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road?","volume":"15","author":"Galipeau","year":"2013","journal-title":"Cytotherapy"},{"key":"2022011118404299700_stem1452-bib-0071","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1002\/stem.1118","article-title":"Analysis of tissues following mesenchymal stromal cell therapy in humans indicates limited long-term engraftment and no ectopic tissue formation","volume":"30","author":"Bahr","year":"2012","journal-title":"Stem Cells"},{"key":"2022011118404299700_stem1452-bib-0072","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1038\/leu.2011.384","article-title":"Mesenchymal stromal cells for the treatment of graft-versus-host disease: Understanding the in vivo biological effect through patient immune monitoring","volume":"26","author":"Dander","year":"2012","journal-title":"Leukemia"},{"key":"2022011118404299700_stem1452-bib-0073","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1182\/blood-2012-03-420612","article-title":"Mesenchymal stem cells are injured by complement after their contact with serum","volume":"120","author":"Li","year":"2012","journal-title":"Blood"},{"key":"2022011118404299700_stem1452-bib-0074","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1634\/stemcells.2008-0146","article-title":"Mesenchymal stem cells alter migratory property of T and dendritic cells to delay the development of murine lethal acute graft-versus-host disease","volume":"26","author":"Li","year":"2008","journal-title":"Stem Cells"},{"key":"2022011118404299700_stem1452-bib-0075","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.bbmt.2010.04.014","article-title":"Efficacy and safety of ex vivo cultured adult human mesenchymal stem cells (Prochymal\u2122) in pediatric patients with severe refractory acute graft-versus-host disease in a compassionate use study","volume":"17","author":"Prasad","year":"2011","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Stem Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fstem.1452","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/stem.1452","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/stem.1452","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/stmcls\/article-pdf\/31\/10\/2033\/41980009\/stmcls_31_10_2033.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/stmcls\/article-pdf\/31\/10\/2033\/41980009\/stmcls_31_10_2033.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T02:50:21Z","timestamp":1642560621000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/stmcls\/article\/31\/10\/2033-2041\/6408079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,1]]},"references-count":75,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2013,10,28]]},"published-print":{"date-parts":[[2013,10,1]]}},"URL":"https:\/\/doi.org\/10.1002\/stem.1452","relation":{},"ISSN":["1066-5099","1549-4918"],"issn-type":[{"value":"1066-5099","type":"print"},{"value":"1549-4918","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2013,10,1]]},"published":{"date-parts":[[2013,10,1]]}}}